Xiou Cao Ph.D. (Duke University); B.S. (Peking University)
Senior Scientist, Novo Nordisk Reseach Centre China, Beijing · China
Editorial leadership for International Journal of Clinical Microbiology ISSN 2690-4721
Research interests
- Molecular Biology
- Protein Engineering
- Antibody Discovery
- Phage Display
- Assay Development
- Inflammation
- Infectious Diseases
Biography
Xiou Cao, PhD, is a Senior Scientist at Novo Nordisk Research Centre China in Beijing, where his work focuses on molecular biology, protein engineering, antibody discovery, phage display, and assay development. He received his doctoral training at Duke University, where he studied host-pathogen interactions and neural regulation of immunity using C. elegans as a model organism, highlighting the role of dopamine signaling and dopamine neural circuits in regulating the p38/PMK-1 MAPK pathway. He also holds a degree from Peking University. His most-cited publication, "Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection" (2019), has been cited 435 times and reflects his contributions to understanding immune mechanisms at the intersection of viral and bacterial infections.
Selected publications
- Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection 2019 cited 435×
- Filamentous bacteriophages are associated with chronic Pseudomonas lung infections and antibiotic resistance in cystic fibrosis 2019 cited 124×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJCM for your work?
This journal is guided by Xiou Cao (Senior Scientist, Novo Nordisk Reseach Centre China, Beijing) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.